The Application segment of the Depth Electrodes market is divided into four primary categories: Neurological, Cardiac, Oncological, and Research. Neurological applications, which include deep brain stimulation for movement disorders and epilepsy, dominate the market, accounting for roughly 45% of total revenue due to high procedure volumes and established reimbursement pathways. Cardiac uses, such as intracardiac mapping and ablation, contribute about 30%, driven by rising incidence of arrhythmias and expanding catheter‑based therapies. Oncological deployment, primarily for tumor ablation and targeted drug delivery, represents 15% of the market, reflecting growing interest in minimally invasive cancer treatments. The remaining 10% stems from Research activities, encompassing pre‑clinical studies and exploratory clinical trials that sustain innovation pipelines. Collectively, these application categories shape the overall market size and are central to the Depth Electrodes segmentation analysis.